• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性放射综合征。献给威廉·迈克尔·考特-布朗的纪念文章。

The acute radiation syndrome. A memorial to William Michael Court-Brown.

作者信息

Danjoux C E, Rider W D, Fitzpatrick P J

出版信息

Clin Radiol. 1979 Sep;30(5):581-4. doi: 10.1016/s0009-9260(79)80203-2.

DOI:10.1016/s0009-9260(79)80203-2
PMID:466962
Abstract

The pattern of symptoms in 189 patients irradiated with a large single dose to one half of the body are described. Radiation sickness developed in 83 and 39% of upper half-body irradiation and lower half-body irradiation treatments respectively and the incidence is not reduced by sedatives or anti-emetics. Following treatment there is a latent period up to 90 min before a phase of acute upset and nausea and vomiting starts. This phase persists for about 6h with an average of six bouts of vomiting and is then followed by recovery.

摘要

描述了189名接受单次大剂量半身照射患者的症状模式。上半身照射和下半身照射治疗分别有83%和39%的患者出现放射病,镇静剂或止吐药并不能降低发病率。治疗后,在急性不适、恶心和呕吐阶段开始前有长达90分钟的潜伏期。这个阶段持续约6小时,平均呕吐六次,然后恢复。

相似文献

1
The acute radiation syndrome. A memorial to William Michael Court-Brown.急性放射综合征。献给威廉·迈克尔·考特-布朗的纪念文章。
Clin Radiol. 1979 Sep;30(5):581-4. doi: 10.1016/s0009-9260(79)80203-2.
2
[Ondansetron in the prevention of radiation-induced nausea and emesis in patients treated with single-fraction irradiation].[昂丹司琼在单次分割照射治疗患者中预防放射性恶心和呕吐的作用]
Srp Arh Celok Lek. 1996 May-Jun;124(5-6):131-4.
3
Management of radiation-induced nausea and vomiting.放射性恶心和呕吐的管理。
Exp Hematol. 2007 Apr;35(4 Suppl 1):34-6. doi: 10.1016/j.exphem.2007.01.010.
4
Radiation-induced emesis: a prospective observational multicenter Italian trial. The Italian Group for Antiemetic Research in Radiotherapy.放射诱导性呕吐:一项前瞻性观察性多中心意大利试验。意大利放射治疗止吐研究小组。
Int J Radiat Oncol Biol Phys. 1999 Jun 1;44(3):619-25. doi: 10.1016/s0360-3016(99)00055-3.
5
An initial evaluation of Nabilone in the control of radiotherapy-induced nausea and vomiting.
Clin Radiol. 1984 Jul;35(4):265-6. doi: 10.1016/s0009-9260(84)80088-4.
6
A prospective observational trial on emesis in radiotherapy: analysis of 1020 patients recruited in 45 Italian radiation oncology centres.一项关于放射治疗中呕吐的前瞻性观察性试验:在 45 个意大利放射肿瘤学中心招募的 1020 名患者的分析。
Radiother Oncol. 2010 Jan;94(1):36-41. doi: 10.1016/j.radonc.2009.11.001. Epub 2009 Dec 4.
7
Radiotherapy-induced nausea and vomiting (RINV): antiemetic guidelines.放射治疗引起的恶心和呕吐(RINV):止吐指南。
Support Care Cancer. 2005 Feb;13(2):122-8. doi: 10.1007/s00520-004-0705-3. Epub 2004 Dec 8.
8
2016 updated MASCC/ESMO consensus recommendations: prevention of radiotherapy-induced nausea and vomiting.2016年更新的MASCC/ESMO共识建议:预防放疗引起的恶心和呕吐。
Support Care Cancer. 2017 Jan;25(1):309-316. doi: 10.1007/s00520-016-3407-8. Epub 2016 Sep 13.
9
Radiation-induced emesis: effects of ondansetron.辐射诱发的呕吐:昂丹司琼的作用
Semin Oncol. 1992 Dec;19(6 Suppl 15):38-43.
10
Understanding anti-emetics.了解止吐药。
Nurs Times. 1993;89(10):36-8.

引用本文的文献

1
2023 Updated MASCC/ESMO Consensus Recommendations: prevention of radiotherapy- and chemoradiotherapy-induced nausea and vomiting.2023 年更新的 MASCC/ESMO 共识推荐意见:预防放疗和放化疗引起的恶心和呕吐。
Support Care Cancer. 2023 Dec 15;32(1):26. doi: 10.1007/s00520-023-08226-z.
2
Furazolidone Increases Survival of Mice Exposed to Lethal Total Body Irradiation through the Antiapoptosis and Antiautophagy Mechanism.呋喃唑酮通过抗细胞凋亡和抗自噬机制提高致死全身放射暴露小鼠的存活率。
Oxid Med Cell Longev. 2021 Feb 4;2021:6610726. doi: 10.1155/2021/6610726. eCollection 2021.
3
Radiation-induced nausea and vomiting: a comparison between MASCC/ESMO, ASCO, and NCCN antiemetic guidelines.
放射性恶心和呕吐:MASCC/ESMO、ASCO 和 NCCN 止吐指南比较。
Support Care Cancer. 2019 Mar;27(3):783-791. doi: 10.1007/s00520-018-4586-2. Epub 2019 Jan 3.
4
A History of Drug Discovery for Treatment of Nausea and Vomiting and the Implications for Future Research.治疗恶心和呕吐的药物发现史及其对未来研究的启示
Front Pharmacol. 2018 Sep 4;9:913. doi: 10.3389/fphar.2018.00913. eCollection 2018.
5
Radiation-induced nausea and vomiting: Is ABO blood group as important as radiation and patient-related factors? An observational study.辐射诱发的恶心和呕吐:ABO血型与辐射及患者相关因素同样重要吗?一项观察性研究。
Medicine (Baltimore). 2016 Aug;95(31):e4334. doi: 10.1097/MD.0000000000004334.
6
Factors influencing the choice of 5-HT3-receptor antagonist antiemetics: focus on elderly cancer patients.影响5-羟色胺3受体拮抗剂类止吐药选择的因素:聚焦老年癌症患者
Support Care Cancer. 2004 Jul;12(7):487-96. doi: 10.1007/s00520-004-0596-3. Epub 2004 Mar 4.
7
Dolasetron. A review of its pharmacology and therapeutic potential in the management of nausea and vomiting induced by chemotherapy, radiotherapy or surgery.多拉司琼。对其在治疗化疗、放疗或手术引起的恶心和呕吐方面的药理学及治疗潜力的综述。
Drugs. 1997 Aug;54(2):273-98. doi: 10.2165/00003495-199754020-00008.
8
A double-blind, placebo-controlled trial of i.v. dolasetron mesilate in the prevention of radiotherapy-induced nausea and vomiting in cancer patients.一项关于静脉注射甲磺酸多拉司琼预防癌症患者放疗引起的恶心和呕吐的双盲、安慰剂对照试验。
Support Care Cancer. 1996 Sep;4(5):378-83. doi: 10.1007/BF01788845.
9
Proinflammatory effects of local abdominal irradiation on rat gastrointestinal tract.局部腹部照射对大鼠胃肠道的促炎作用。
Dig Dis Sci. 1989 Mar;34(3):390-9. doi: 10.1007/BF01536261.
10
Tropisetron, a new 5-HT3-receptor antagonist, in the prevention of radiation-induced nausea, vomiting and diarrhoea.托烷司琼,一种新型5-羟色胺3受体拮抗剂,用于预防放疗引起的恶心、呕吐和腹泻。
Drugs. 1992;43 Suppl 3:33-9. doi: 10.2165/00003495-199200433-00008.